![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Metrochem API Private Limited](https://www.pharmacompass.com/image/flap/metrochem-desktop-header-w24-1gif-62145.gif)
![Metrochem API Private Limited](https://www.pharmacompass.com/image/flap/metrochem-mobgif-80388.gif)
Active Filter(s):
Details:
Actonel (risedronate sodium hydrate) tablet act as inhibits osteoclasts, which is indicated for the treatment of Paget’s disease and treatment and prevention of postmenopausal osteoporosis.
Lead Product(s): Risedronate Sodium
Therapeutic Area: Rare Diseases and Disorders Product Name: Actonel
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: Eisai
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable March 19, 2020